XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.22.4

Income Taxes | 12 Months Ended
--- | ---
Dec. 25, 2022
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes Loss before income taxes includes the following components for the fiscal years ended December 25, 2022, December 26, 2021, and December 27, 2020 (in thousands):
|  | 2022 |  | 2021 |  | 2020
U.S. |  | $ | (76,893) |  |  | $ | (49,978) |  |  | $ | (262,728) |
Foreign |  | (160) |  |  | (176) |  |  | (20,824) |
Loss before income taxes |  | $ | (77,053) |  |  | $ | (50,154) |  |  | $ | (283,552) |
The benefit for income taxes for the fiscal years ended December 25, 2022, December 26, 2021, and December 27, 2020 consist of the following (in thousands):
|  | 2022 |  | 2021 |  | 2020
Current: |  |  |  |  |  |
Federal |  | $ | 374 |  |  | $ | — |  |  | $ | (60,340) |
State |  | 373 |  |  | (152) |  |  | 1,354 |
Foreign |  | — |  |  | — |  |  | — |
Total current income tax (benefit) |  | $ | 747 |  |  | $ | (152) |  |  | $ | (58,986) |
Deferred: |  |  |  |  |  |
Federal |  | $ | — |  |  | $ | — |  |  | $ | 44,353 |
State |  | — |  |  | — |  |  | 8,086 |
Foreign |  | — |  |  | — |  |  | (937) |
Total deferred income tax expense (benefit) |  | — |  |  | — |  |  | 51,502 |
Income tax benefit |  | $ | 747 |  |  | $ | (152) |  |  | $ | (7,484) |
The reconciliation between the income tax benefit and the amount of income tax computed by applying the U.S. federal statutory rate to loss before income taxes as shown in the accompanying Consolidated Statements of Operations and Comprehensive Loss for fiscal years ended December 25, 2022, December 26, 2021, and December 27, 2020 is as follows:
|  | 2022 |  | 2021 |  | 2020
Tax provision at U.S. federal statutory rate |  | 21.0 | % |  | 21.0 | % |  | 21.0 | %
State income taxes |  | 4.0 |  |  | 3.8 |  |  | 3.9 |
Foreign taxes versus U.S statutory rate |  | — |  |  | — |  |  | 0.2 |
Valuation allowance on deferred income tax assets |  | (24.2) |  |  | (25.2) |  |  | (27.9) |
Impact of CARES Act and related method changes |  | — |  |  | — |  |  | 5.5 |
Excess stock options |  | (1.1) |  |  | 1.1 |  |  | (0.1) |
Other |  | (0.7) |  |  | (0.4) |  |  | — |
Effective tax rate |  | (1.0) | % |  | 0.3 | % |  | 2.6 | %
The increase in tax expense for the year ended December 25, 2022, is primarily due to the 2022 impact of state taxes including minimum state income taxes and state franchise taxes as well as an adjustment to federal taxes. The decrease in the Company's effective tax benefit in 2021 is primarily due to the 2020 favorable rate impact of net operating loss carrybacks allowed as part of the CARES Act. The Company's federal and state deferred taxes at December 25, 2022 and December 26, 2021 are as follows (in thousands):
|  | 2022 |  | 2021
Deferred tax assets: |  |  |  |
Leasing transactions |  | $ | 115,832 |  |  | $ | 126,981 |
General business and other tax credits |  | 40,802 |  |  | 40,472 |
Net operating loss carryover |  | 48,341 |  |  | 36,069 |
Accrued compensation and related costs |  | 8,651 |  |  | 9,738 |
Goodwill |  | 7,851 |  |  | 8,296 |
Stock-based compensation |  | 7,309 |  |  | 6,461 |
Advanced payments |  | 1,371 |  |  | 3,912 |
Other non-current deferred tax assets |  | 8,726 |  |  | 5,782 |
Subtotal |  | 238,883 |  |  | 237,711 |
Valuation allowance |  | (116,284) |  |  | (99,093) |
Total |  | $ | 122,599 |  |  | $ | 138,618 |
Deferred tax liabilities: |  |  |  |
Leasing transactions |  | $ | (97,871) |  |  | $ | (108,067) |
Property and equipment |  | (11,550) |  |  | (17,600) |
Supplies inventory |  | (4,047) |  |  | (4,128) |
Prepaid expenses |  | (1,906) |  |  | (2,517) |
Other non-current deferred tax liabilities |  | (7,225) |  |  | (6,306) |
Total |  | $ | (122,599) |  |  | $ | (138,618) |
Net deferred tax asset |  | $ | — |  |  | $ | — |
The Company had net operating loss carryforwards for tax purposes of $48.3 million as of December 25, 2022. This is comprised of approximately $21.8 million of federal net operating loss carryovers, approximately $17.6 million of state net operating loss carryovers, and approximately $8.9 million of foreign net operating loss carryovers. The federal net operating loss has an indefinite carryforward period, the state net operating loss carryovers expire at various dates between 2025 and 2042, and the foreign net operating loss carryovers expire at various dates between 2035 and 2042. As of December 25, 2022, the Company had a deferred tax asset of $39.6 million related to federal tax credits, which expire at various dates between 2037 and 2041. The Company also had a deferred tax asset of $1.2 million related to state tax credits which expire in 2024. The Company establishes a valuation allowance to reduce the carrying amount of deferred income tax assets when it is more likely than not that it will not realize some portion or all the tax benefit of its deferred income tax assets. The realization of deferred tax assets depends on the generation of future taxable income during the periods in which the temporary differences become deductible. In making this determination, the Company considers all available positive and negative evidence including historical operating losses, the reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies. In 2020, management determined that a full valuation allowance was required and has recorded a full valuation allowance as of December 25, 2022 and at December 26, 2021. Based on the Company's evaluation of its deferred tax assets, a valuation allowance of approximately $116.3 million has been recorded against the deferred tax asset for federal and state tax credits, federal and state deferred tax assets, all net operating loss carry forwards and the deferred taxes of our foreign subsidiary. The following table summarizes the Company's unrecognized tax benefits at December 25, 2022, December 26, 2021, and December 27, 2020 (in thousands):
|  | 2022 |  | 2021 |  | 2020
Beginning of year |  | $ | 32 |  |  | $ | 80 |  |  | $ | 104 |
Increase due to current year tax positions |  | 177 |  |  | 3 |  |  | — |
Due to decrease to a position taken in a prior year |  | — |  |  | — |  |  | (24) |
Settlements |  | — |  |  | — |  |  | — |
Reductions related to lapses in the statute of limitations |  | (24) |  |  | (51) |  |  | — |
End of year |  | $ | 185 |  |  | 32 |  |  | $ | 80 |
The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate is approximately $0.2 million. The Company does not anticipate significant changes in the aggregate amount of unrecognized tax benefits within the next 12 months, other than nominal tax settlements. The Company had outstanding federal and state refund claims of approximately $0.6 million as of December 25, 2022. Recent Tax Legislation The CHIPS and Science Act of 2022 (CHIPS) and the Inflation Reduction Act (IRA) of 2022 were signed into law by President Biden on August 9, 2022 and August 16, 2022, respectively. The legislation introduces new options for monetizing certain credits, a corporate alternative minimum tax, and a stock repurchase excise tax. The Company is currently evaluating the impact of CHIPS and IRA, but at present does not expect that any of the provisions included in these Acts would result in a material impact to our deferred tax assets, liabilities, or income taxes payable.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 14 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 270 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -URI https://asc.fasb.org/topic&trid=2144680 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration